AVROBIO

-$0.06 (-0.82%) As of 7:57 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVROBIO and other ETFs, options, and stocks.

About AVRO

Avrobio, Inc. engages in the development of lentiviral-based gene therapies. It focuses on developing potentially curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen.

CEO
Geoff MacKay
Employees
—
Headquarters
Cambridge, Massachusetts
Founded
2015

AVRO Key Statistics

Market Cap
378.31M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
218.35K
High Today
$7.42
Low Today
$7.11
Open Price
$7.21
Volume
109.42K
52 Week High
$20.07
52 Week Low
$7.11

AVRO Earnings

-$1.01
-$0.67
-$0.34
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 12, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure